Flunarizine is a calcium channel blocker widely used in neurological disorders; however, its low aqueous solubility may influence formulation stability and drug dispersion in polymer-based systems. The present study aimed to evaluate the compatibility of flunarizine with selected excipients and to investigate its incorporation into polymeric hydrogel matrices. Binary mixtures of flunarizine with excipients such as hydroxypropyl-β-cyclodextrin, polyethylene glycol (PEG 6000), Tween 20, gelatin, and citric acid were prepared and characterized using Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TG/DTG), and high-performance liquid chromatography (HPLC). The FTIR spectra of the analyzed samples do not reveal the appearance of new absorption bands that may indicate chemical interactions; instead, minor spectral variations were observed due to weak intermolecular interactions within the polymer network. Thermal analysis revealed decomposition patterns consistent with those of the individual components, suggesting the absence of significant incompatibilities. A validated RP-HPLC method enabled sensitive and reliable quantification of flunarizine in the analyzed systems, with a limit of detection (LOD) of 0.05 µg/mL and a limit of quantitation (LOQ) of 0.16 µg/mL. Accuracy testing showed average recovery rates of 100% across 80–120% spiking levels. Overall, the results support the compatibility of flunarizine with the investigated excipients and the suitability of the studied hydrogels as potential drug delivery matrices.
Ionaș et al. (Wed,) studied this question.